Advertisement

Sleep Disturbance and Risk of Active Disease in Patients With Crohn's Disease and Ulcerative Colitis

Published:February 04, 2013DOI:https://doi.org/10.1016/j.cgh.2013.01.021

      Background & Aims

      Impairment of sleep quality is common in patients with inflammatory bowel diseases (IBDs) (eg, Crohn's disease [CD] and ulcerative colitis [UC]), even during clinical remission. Sleep impairment can activate inflammatory pathways. Few prospective studies have examined the role of sleep disturbance on risk of relapse in IBD.

      Methods

      We analyzed data from 3173 patients with IBD (1798 in clinical remission at baseline) participating in the Crohn's and Colitis Foundation of America Partners study, a longitudinal, Internet-based cohort. Sleep disturbance was measured using a subset of questions from the Patient Reported Outcomes Measurement Information Systems sleep disturbance questionnaire. Disease activity was assessed using the short Crohn's Disease Activity Index and the simple clinical colitis activity index for CD and UC, respectively. Logistic regression was used to identify predictors of sleep quality and examine the effect of sleep quality at baseline among patients in remission on risk of active disease at 6 months.

      Results

      Disease activity, depression, female sex, smoking, and use of corticosteroids or narcotics were associated with sleep disturbance at enrollment. Among 1291 patients whose CD was in remission at baseline, those with impaired sleep had a 2-fold increase in risk of active disease at 6 months (adjusted odds ratio, 2.00; 95% confidence interval, 1.45–2.76); however, no effect was observed in patients with UC (odds ratio, 1.14; 95% confidence interval, 0.75–1.74). These findings persisted in a number of sensitivity analyses.

      Conclusions

      Sleep disturbance was associated with an increased risk of disease flares in CD but not UC. These findings indicate that the evaluation and treatment of sleep disturbance in patients with CD might improve outcomes.

      Keywords

      Abbreviations used in this paper:

      CCFA (Crohn's and Colitis Foundation of America), CD (Crohn's disease), CI (confidence interval), DSS (dextran sodium sulfate), IBD (inflammatory bowel diseases), IL (interleukin), OR (odds ratio), PROMIS (Patient Reported Outcomes Measurement Information Systems), PSQI (Pittsburgh Sleep Quality Index), SCCAI (Simple Clinical Colitis Activity Index), SCDAI (Short Crohn's Disease Activity Index), TNF (tumor necrosis factor), UC (ulcerative colitis)
      To read this article in full you will need to make a payment
      AGA Member Login
      Login with your AGA username and password.

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abraham C.
        • Cho J.H.
        Inflammatory bowel disease.
        N Engl J Med. 2009; 361: 2066-2078
        • Loftus Jr, E.V.
        • Sandborn W.J.
        Epidemiology of inflammatory bowel disease.
        Gastroenterol Clin North Am. 2002; 31: 1-20
        • Bernstein C.N.
        • Loftus Jr, E.V.
        • Ng S.C.
        • et al.
        Hospitalisations and surgery in Crohn's disease.
        Gut. 2012; 61: 622-629
        • Hommes D.
        • Colombel J.F.
        • Emery P.
        • et al.
        Changing Crohn's disease management: need for new goals and indices to prevent disability and improve quality of life.
        J Crohns Colitis. 2012; 6: S224-S234
        • Cosnes J.
        • Gower-Rousseau C.
        • Seksik P.
        • et al.
        Epidemiology and natural history of inflammatory bowel diseases.
        Gastroenterology. 2011; 140: 1785-1794
        • Danese S.
        • Fiocchi C.
        Etiopathogenesis of inflammatory bowel diseases.
        World J Gastroenterol. 2006; 12: 4807-4812
        • Khor B.
        • Gardet A.
        • Xavier R.J.
        Genetics and pathogenesis of inflammatory bowel disease.
        Nature. 2011; 474: 307-317
        • Lakatos P.L.
        Environmental factors affecting inflammatory bowel disease: have we made progress?.
        Dig Dis. 2009; 27: 215-225
        • Baglioni C.
        • Battagliese G.
        • Feige B.
        • et al.
        Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies.
        J Affect Disord. 2011; 135: 10-19
        • Gangwisch J.E.
        • Heymsfield S.B.
        • Boden-Albala B.
        • et al.
        Sleep duration associated with mortality in elderly, but not middle-aged, adults in a large US sample.
        Sleep. 2008; 31: 1087-1096
        • Hall M.H.
        • Muldoon M.F.
        • Jennings J.R.
        • et al.
        Self-reported sleep duration is associated with the metabolic syndrome in midlife adults.
        Sleep. 2008; 31: 635-643
        • Abad V.C.
        • Sarinas P.S.
        • Guilleminault C.
        Sleep and rheumatologic disorders.
        Sleep Med Rev. 2008; 12: 211-228
        • Graff L.A.
        • Walker J.R.
        • Russell A.S.
        • et al.
        Fatigue and quality of sleep in patients with immune-mediated inflammatory disease.
        J Rheumatol Suppl. 2011; 88: 36-42
        • Keefer L.
        • Stepanski E.J.
        • Ranjbaran Z.
        • et al.
        An initial report of sleep disturbance in inactive inflammatory bowel disease.
        J Clin Sleep Med. 2006; 2: 409-416
        • Ranjbaran Z.
        • Keefer L.
        • Farhadi A.
        • et al.
        Impact of sleep disturbances in inflammatory bowel disease.
        J Gastroenterol Hepatol. 2007; 22: 1748-1753
        • Ranjbaran Z.
        • Keefer L.
        • Stepanski E.
        • et al.
        The relevance of sleep abnormalities to chronic inflammatory conditions.
        Inflamm Res. 2007; 56: 51-57
        • Swanson G.R.
        • Burgess H.J.
        • Keshavarzian A.
        Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare?.
        Expert Rev Clin Immunol. 2011; 7: 29-36
        • Tang Y.
        • Preuss F.
        • Turek F.W.
        • et al.
        Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis.
        Sleep Med. 2009; 10: 597-603
        • Ruperto N.
        • Lovell D.J.
        • Li T.
        • et al.
        Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis.
        Arthritis Care Res (Hoboken). 2010; 62: 1542-1551
        • Cohen A.B.
        • Lee D.
        • Long M.D.
        • et al.
        Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease.
        Dig Dis Sci. 2012; (Epub ahead of print)
        • Long M.D.
        • Kappelman M.D.
        • Martin C.F.
        • et al.
        Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results.
        Inflamm Bowel Dis. 2012; 18: 2099-2106
        • Buysse D.J.
        • Yu L.
        • Moul D.E.
        • et al.
        Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments.
        Sleep. 2010; 33: 781-792
        • Yu L.
        • Buysse D.J.
        • Germain A.
        • et al.
        Development of short forms from the PROMIS sleep disturbance and sleep-related impairment item banks.
        Behav Sleep Med. 2012; 10: 6-24
        • Buysse D.J.
        • Reynolds 3rd, C.F.
        • Monk T.H.
        • et al.
        The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.
        Psychiatry Res. 1989; 28: 193-213
        • Bjorner J.B.
        • Chang C.H.
        • Thissen D.
        • et al.
        Developing tailored instruments: item banking and computerized adaptive assessment.
        Qual Life Res. 2007; 16: 95-108
        • Silverberg M.S.
        • Satsangi J.
        • Ahmad T.
        • et al.
        Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology.
        Can J Gastroenterol. 2005; 19: 5-36
        • Best W.R.
        • Becktel J.M.
        • Singleton J.W.
        • et al.
        Development of a Crohn's disease activity index. National cooperative Crohn's disease study.
        Gastroenterology. 1976; 70: 439-444
        • Walmsley R.S.
        • Ayres R.C.
        • Pounder R.E.
        • et al.
        A simple clinical colitis activity index.
        Gut. 1998; 43: 29-32
        • Morisky D.E.
        • Ang A.
        • Krousel-Wood M.
        • et al.
        Predictive validity of a medication adherence measure in an outpatient setting.
        J Clin Hypertens (Greenwich). 2008; 10: 348-354
        • Brass S.D.
        • Duquette P.
        • Proulx-Therrien J.
        • et al.
        Sleep disorders in patients with multiple sclerosis.
        Sleep Med Rev. 2010; 14: 121-129
        • Chandrasekhara P.K.
        • Jayachandran N.V.
        • Rajasekhar L.
        • et al.
        The prevalence and associations of sleep disturbances in patients with systemic lupus erythematosus.
        Mod Rheumatol. 2009; 19: 407-415
        • Fragiadaki K.
        • Tektonidou M.G.
        • Konsta M.
        • et al.
        Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis.
        J Rheumatol. 2012; 39: 60-62
        • Graff L.A.
        • Vincent N.
        • Walker J.R.
        • et al.
        A population-based study of fatigue and sleep difficulties in inflammatory bowel disease.
        Inflamm Bowel Dis. 2011; 17: 1882-1889
        • Hall M.H.
        • Okun M.L.
        • Sowers M.
        • et al.
        Sleep is associated with the metabolic syndrome in a multi-ethnic cohort of midlife women: the SWAN sleep study.
        Sleep. 2012; 35: 783-790
        • Irwin M.R.
        • Olmstead R.
        • Carrillo C.
        • et al.
        Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis.
        Sleep. 2012; 35: 537-543
        • Luyster F.S.
        • Chasens E.R.
        • Wasko M.C.
        • et al.
        Sleep quality and functional disability in patients with rheumatoid arthritis.
        J Clin Sleep Med. 2011; 7: 49-55
        • Simpson N.
        • Dinges D.F.
        Sleep and inflammation.
        Nutr Rev. 2007; 65: S244-S252
        • Graff L.A.
        • Walker J.R.
        • Bernstein C.N.
        Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management.
        Inflamm Bowel Dis. 2009; 15: 1105-1118
        • Shoham S.
        • Davenne D.
        • Cady A.B.
        • et al.
        Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep.
        Am J Physiol. 1987; 253: R142-R149
        • Rohleder N.
        • Aringer M.
        • Boentert M.
        Role of interleukin-6 in stress, sleep, and fatigue.
        Ann N Y Acad Sci. 2012; 1261: 88-96
        • Lange T.
        • Dimitrov S.
        • Born J.
        Effects of sleep and circadian rhythm on the human immune system.
        Ann N Y Acad Sci. 2010; 1193: 48-59